Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Amino Acid metabolism WP3925,0.00477735323974973,3.318262636525273,17.73235951442452,"['GLUD1', 'MAOA', 'RARS', 'ALDH1A1', 'ODC1', 'GSR', 'FAH', 'FARSB']",0.7804755178600928,0,0,8
2,Eicosanoid Synthesis WP167,0.005291359443119274,10.959899749373433,57.44828822303688,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.7804755178600928,0,0,3
3,Prostaglandin Synthesis and Regulation WP98,0.010109257588950931,5.389391447368421,24.760500970299454,"['CBR1', 'CYP11A1', 'TBXAS1', 'PTGDS']",0.8907967115847576,0,0,4
4,Sulfation Biotransformation Reaction WP692,0.019356837287751866,12.764591439688717,50.352606056699216,"['SULT1A1', 'GSR']",0.8907967115847576,0,0,2
5,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.020864185376850832,5.898785425101215,22.82665506253198,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.8907967115847576,0,0,3
6,Urea cycle and metabolism of amino groups WP497,0.024638561839608584,5.47702589807853,20.283850533395572,"['GLUD1', 'ACY1', 'ODC1']",0.8907967115847576,0,0,3
7,Methionine De Novo and Salvage Pathway WP3580,0.033211892508728975,4.791666666666667,16.314893116552703,"['AHCY', 'ODC1', 'MTR']",0.8907967115847576,0,0,3
8,Arylamine metabolism WP694,0.03782417250307553,inf,inf,['SULT1A1'],0.8907967115847576,0,0,1
9,Sleep regulation WP3591,0.03800540745210874,4.5094599243206055,14.746054932356877,"['OXTR', 'AHCY', 'PTGDS']",0.8907967115847576,0,0,3
10,DNA Replication WP466,0.038272827587490156,3.410416666666667,11.128241070566828,"['POLD3', 'RFC3', 'ORC3', 'MCM5']",0.8907967115847576,0,0,4
11,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.04309576515971027,7.292384658143413,22.92966781084829,"['ALDH1A1', 'MTR']",0.8907967115847576,0,0,2
12,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.04309576515971027,7.292384658143413,22.92966781084829,"['AHCY', 'MTR']",0.8907967115847576,0,0,2
13,Ciliary landscape WP4352,0.04641153277138383,1.7502836384832368,5.373733603112556,"['NEK8', 'INTU', 'TFAP2E', 'EIPR1', 'DCAF7', 'LRPPRC', 'EXOSC7', 'AFG3L2', 'MSH2', 'EXOSC9', 'XPNPEP3', 'MCM5', 'SNAP29']",0.8907967115847576,0,0,13
14,DNA Mismatch Repair WP531,0.04858267741168824,4.034164358264081,12.201282673798996,"['POLD3', 'RFC3', 'MSH2']",0.8907967115847576,0,0,3
15,Trans-sulfuration pathway WP2333,0.05254688244984763,6.38035019455253,18.796827556801105,"['AHCY', 'MTR']",0.8907967115847576,0,0,2
16,Iron metabolism in placenta WP2007,0.05254688244984763,6.38035019455253,18.796827556801105,"['FTH1', 'ACO1']",0.8907967115847576,0,0,2
17,Oxidative Stress WP408,0.054353697656019107,3.8321637426900583,11.16019063032053,"['MAOA', 'TXNRD1', 'GSR']",0.8907967115847576,0,0,3
18,Photodynamic therapy-induced unfolded protein response WP3613,0.054353697656019107,3.8321637426900583,11.16019063032053,"['DNAJB11', 'EIF2AK3', 'CALR']",0.8907967115847576,0,0,3
19,Ethanol effects on histone modifications WP3996,0.0668218072484863,3.4832535885167464,9.42472908810745,"['AHCY', 'ALDH1A1', 'MTR']",0.9532955575088616,0,0,3
20,One-carbon metabolism WP241,0.07350114175161049,3.3315535214848717,8.69686834526612,"['MTFMT', 'AHCY', 'MTR']",0.9532955575088616,0,0,3
21,Melatonin metabolism and effects WP3298,0.0804644651010068,3.192495126705653,8.044894954309987,"['SULT1A1', 'MAOA', 'CRY2']",0.9532955575088616,0,0,3
22,Nucleotide Excision Repair WP4753,0.08381614394080662,2.555859375,6.336306736298493,"['POLD3', 'DDB1', 'RFC3', 'GTF2H3']",0.9532955575088616,0,0,4
23,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.08457787931050212,4.639193491333569,11.459190751841916,"['RAB27A', 'UNC13D']",0.9532955575088616,0,0,2
24,Cysteine and methionine catabolism WP4504,0.09628389536097845,4.252269779507134,9.952242699905703,"['AHCY', 'MTR']",0.9532955575088616,0,0,2
25,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.10104207539047359,2.376998546511628,5.448599474363721,"['TRAF3', 'DHX58', 'TRIM25', 'ISG15']",0.9532955575088616,0,0,4
26,Retinoblastoma gene in cancer WP2446,0.1039471263667103,2.0956979243527636,4.7443937573121095,"['POLD3', 'RFC3', 'PRKDC', 'HMGB2', 'HMGB1']",0.9532955575088616,0,0,5
27,Constitutive Androstane Receptor Pathway WP2875,0.10841490413843718,3.9248727925770726,8.720241973306871,"['SULT1A1', 'DNAJC7']",0.9532955575088616,0,0,2
28,Mitochondrial complex III assembly WP4921,0.10841490413843718,3.9248727925770726,8.720241973306871,"['UQCR10', 'UQCRC2']",0.9532955575088616,0,0,2
29,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.109242549887937,12.741747572815534,28.212581769839087,['TRAF3'],0.9532955575088616,0,0,1
30,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.109242549887937,12.741747572815534,28.212581769839087,['GLUD1'],0.9532955575088616,0,0,1
31,Fatty Acid Omega Oxidation WP206,0.109242549887937,12.741747572815534,28.212581769839087,['ALDH1A1'],0.9532955575088616,0,0,1
32,Vitamin D-sensitive calcium signaling in depression WP4698,0.11094629504081376,2.735588972431078,6.014764157488097,"['CYP27A1', 'GSR', 'ATP2B2']",0.9532955575088616,0,0,3
33,Selenium Micronutrient Network WP15,0.11335878599055858,2.2710069444444443,4.9444303988957925,"['TXNRD1', 'GSR', 'MTR', 'SELENOI']",0.9532955575088616,0,0,4
34,DNA Repair Pathways Full Network WP4946,0.1232103371817449,1.7388177847292425,3.6408450507132084,"['DDB1', 'POLD3', 'RFC3', 'MSH2', 'PRKDC', 'HMGB1', 'GTF2H3']",0.9532955575088616,0,0,7
35,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.13299606340674297,2.1285807291666665,4.294274859024057,"['RSAD2', 'ISG15', 'IFI44L', 'PLCD1']",0.9532955575088616,0,0,4
36,Somatic sex determination WP4814,0.1429422467462055,8.493851132686084,16.523212611904267,['PTGDS'],0.9532955575088616,0,0,1
37,Tamoxifen metabolism WP691,0.1429422467462055,8.493851132686084,16.523212611904267,['SULT1A1'],0.9532955575088616,0,0,1
38,The alternative pathway of fetal androgen synthesis WP4524,0.1429422467462055,8.493851132686084,16.523212611904267,['CYP11A1'],0.9532955575088616,0,0,1
39,Fas ligand pathway and stress induction of heat shock proteins WP314,0.14509239042087005,2.3929093567251463,4.619235285644822,"['DFFA', 'PRKDC', 'NFX1']",0.9532955575088616,0,0,3
40,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.16025897687812526,3.000457770656901,5.493730662039648,"['H2AFY', 'H2AFY2']",0.9532955575088616,0,0,2
41,PKC-gamma calcium signaling pathway in ataxia WP4760,0.16025897687812526,3.000457770656901,5.493730662039648,"['CACNA1A', 'ATP2B2']",0.9532955575088616,0,0,2
42,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.17265718977448521,2.187301587301587,3.841879775634869,"['TRAF3', 'DHX58', 'TRIM25']",0.9532955575088616,0,0,3
43,7-oxo-C and 7beta-HC pathways WP5064,0.1738427123860079,2.8335495028102033,4.957590508806752,"['CYP27A1', 'ACOT11']",0.9532955575088616,0,0,2
44,Striated Muscle Contraction Pathway WP383,0.1738427123860079,2.8335495028102033,4.957590508806752,"['ACTN2', 'MYL3']",0.9532955575088616,0,0,2
45,Serotonin Transporter Activity WP1455,0.17536937555205068,6.3699029126213595,11.089114357163757,['MAOA'],0.9532955575088616,0,0,1
46,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.17536937555205068,6.3699029126213595,11.089114357163757,['CYP11A1'],0.9532955575088616,0,0,1
47,Vitamin D Metabolism WP1531,0.17536937555205068,6.3699029126213595,11.089114357163757,['CYP27A1'],0.9532955575088616,0,0,1
48,Molybdenum cofactor (Moco) biosynthesis WP4507,0.17536937555205068,6.3699029126213595,11.089114357163757,['GPHN'],0.9532955575088616,0,0,1
49,NAD Biosynthesis II (from tryptophan) WP2485,0.17536937555205068,6.3699029126213595,11.089114357163757,['NADSYN1'],0.9532955575088616,0,0,1
50,Osteoblast Signaling WP322,0.17536937555205068,6.3699029126213595,11.089114357163757,['BGLAP'],0.9532955575088616,0,0,1
51,Glycogen Synthesis and Degradation WP500,0.1821554897788473,2.126380766731644,3.6210023617877796,"['PYGB', 'PPP2R2C', 'PPP2R2B']",0.9532955575088616,0,0,3
52,Regulation of Microtubule Cytoskeleton WP2038,0.1821554897788473,2.126380766731644,3.6210023617877796,"['TESK2', 'MAPT', 'EPHB2']",0.9532955575088616,0,0,3
53,Proteasome Degradation WP183,0.1835496095876541,1.8566761363636364,3.1475679033616055,"['UBA7', 'UBE2D1', 'PSME2', 'HLA-E']",0.9532955575088616,0,0,4
54,Type II interferon signaling (IFNG) WP619,0.20150377047657886,2.549805447470817,4.084653660729525,"['ISG15', 'GBP1']",0.9532955575088616,0,0,2
55,ATM Signaling Network in Development and Disease  WP3878,0.20154838924100785,2.0141582025238534,3.2261291206173657,"['RNF20', 'PRKDC', 'HMGN1']",0.9532955575088616,0,0,3
56,Peroxiredoxin 2 induced ovarian failure WP4873,0.20657189933453954,5.095533980582524,8.036201017211301,['CYP11A1'],0.9532955575088616,0,0,1
57,Cytosolic DNA-sensing pathway WP4655,0.21142062583875149,1.9623631728894886,3.0493272069437047,"['IL33', 'TRIM25', 'ISG15']",0.9532955575088616,0,0,3
58,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2155180663092606,2.4282008523253658,3.7265854378296583,"['SERPINH1', 'TMEM38B']",0.9532955575088616,0,0,2
59,TYROBP causal network in microglia WP3945,0.22961641531821617,2.3176512203749557,3.4100648171417647,"['ADAP2', 'TMEM106A']",0.9532955575088616,0,0,2
60,Gastric Cancer Network 2 WP2363,0.22961641531821617,2.3176512203749557,3.4100648171417647,"['RFC3', 'DSCC1']",0.9532955575088616,0,0,2
61,Biogenic Amine Synthesis WP550,0.23659597771334973,4.2459546925566345,6.120124732260678,['MAOA'],0.9532955575088616,0,0,1
62,"Cerebral organic acidurias, including diseases WP4519",0.23659597771334973,4.2459546925566345,6.120124732260678,['L2HGDH'],0.9532955575088616,0,0,1
63,Estrogen metabolism WP697,0.23659597771334973,4.2459546925566345,6.120124732260678,['SULT1A1'],0.9532955575088616,0,0,1
64,Ketogenesis and Ketolysis WP4742,0.23659597771334973,4.2459546925566345,6.120124732260678,['CPT2'],0.9532955575088616,0,0,1
65,Ciliopathies WP4803,0.23864153665007823,1.3809321132155778,1.9785894504570039,"['NEK8', 'INTU', 'XPNPEP3', 'CEP83', 'PKD1L1', 'CEP41', 'WDR35', 'GLIS2']",0.9532955575088616,0,0,8
66,Phosphoinositides metabolism WP4971,0.24161053578791233,1.821776663881927,2.58770295746063,"['MTMR12', 'PLCD4', 'PLCD1']",0.9532955575088616,0,0,3
67,PPAR signaling pathway WP3942,0.24161053578791233,1.821776663881927,2.58770295746063,"['CYP27A1', 'CPT2', 'FABP5']",0.9532955575088616,0,0,3
68,Vitamin B12 metabolism WP1533,0.24377247000594854,2.2167145998984945,3.1289369670289635,"['MCEE', 'MTR']",0.9532955575088616,0,0,2
69,Resistin as a regulator of inflammation WP4481,0.24377247000594854,2.2167145998984945,3.1289369670289635,"['PLCD4', 'PLCD1']",0.9532955575088616,0,0,2
70,Metapathway biotransformation Phase I and II WP702,0.2540172120800684,1.5012087026591459,2.0571862248645316,"['CYP27A1', 'SULT1A1', 'CYP11A1', 'GSR', 'NAT10']",0.9532955575088616,0,0,5
71,Vitamin A and carotenoid metabolism WP716,0.257961748503588,2.124189364461738,2.87815756343428,"['SULT1A1', 'ALDH1A1']",0.9532955575088616,0,0,2
72,GABA receptor Signaling WP4159,0.257961748503588,2.124189364461738,2.87815756343428,"['AP2A1', 'GPHN']",0.9532955575088616,0,0,2
73,Oxidation by Cytochrome P450 WP43,0.257961748503588,2.124189364461738,2.87815756343428,"['CYP27A1', 'CYP11A1']",0.9532955575088616,0,0,2
74,Oxysterols derived from cholesterol WP4545,0.257961748503588,2.124189364461738,2.87815756343428,"['CYP27A1', 'ACOT11']",0.9532955575088616,0,0,2
75,Supression of HMGB1 mediated inflammation by THBD WP4479,0.26548603405202886,3.639112343966713,4.826165470077196,['HMGB1'],0.9532955575088616,0,0,1
76,Valproic acid pathway WP3871,0.26548603405202886,3.639112343966713,4.826165470077196,['IVD'],0.9532955575088616,0,0,1
77,Heme Biosynthesis WP561,0.26548603405202886,3.639112343966713,4.826165470077196,['FECH'],0.9532955575088616,0,0,1
78,Leptin and adiponectin WP3934,0.26548603405202886,3.639112343966713,4.826165470077196,['LEPR'],0.9532955575088616,0,0,1
79,NRF2 pathway WP2884,0.268458954119158,1.4664732213149785,1.9284962383710873,"['CBR1', 'FTH1', 'TXNRD1', 'GSR', 'PRDX6']",0.9532955575088616,0,0,5
80,Translation Factors WP107,0.28281901188933856,1.6628527841342486,2.100096797372725,"['EIF2AK3', 'EIF4EBP2', 'EIF3E']",0.9532955575088616,0,0,3
81,Trans-sulfuration and one-carbon metabolism WP2525,0.2863507653900945,1.9604908709967075,2.451667876486619,"['AHCY', 'MTR']",0.9532955575088616,0,0,2
82,Serotonin and anxiety-related events WP3944,0.2932848204093306,3.183980582524272,3.905505793604477,['PLCD4'],0.9532955575088616,0,0,1
83,Vitamin B12 Disorders WP4271,0.2932848204093306,3.183980582524272,3.905505793604477,['MTR'],0.9532955575088616,0,0,1
84,Cytosine methylation WP3585,0.2932848204093306,3.183980582524272,3.905505793604477,['TET3'],0.9532955575088616,0,0,1
85,Dopamine metabolism WP2436,0.2932848204093306,3.183980582524272,3.905505793604477,['MAOA'],0.9532955575088616,0,0,1
86,NLR Proteins WP288,0.2932848204093306,3.183980582524272,3.905505793604477,['EPHB2'],0.9532955575088616,0,0,1
87,Base Excision Repair WP4752,0.30050996689330445,1.8877359850122497,2.2695765691874126,"['POLD3', 'HMGB1']",0.9532955575088616,0,0,2
88,Proximal tubule transport WP4917,0.30050996689330445,1.8877359850122497,2.2695765691874126,"['SLC13A3', 'SLC47A1']",0.9532955575088616,0,0,2
89,Focal Adhesion WP306,0.30946491216583677,1.2943253324221975,1.5181278539681808,"['SHC1', 'COL5A2', 'TESK2', 'ITGA7', 'PARVB', 'TLN1', 'MYLK']",0.9532955575088616,0,0,7
90,15q13.3 copy number variation syndrome WP4942,0.3200334802921868,2.8299892125134845,3.2242906550740043,['SERPINH1'],0.9532955575088616,0,0,1
91,TCA cycle in senescence WP5050,0.3200334802921868,2.8299892125134845,3.2242906550740043,['ME2'],0.9532955575088616,0,0,1
92,Development and heterogeneity of the ILC family WP3893,0.3200334802921868,2.8299892125134845,3.2242906550740043,['IL33'],0.9532955575088616,0,0,1
93,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.3200334802921868,2.8299892125134845,3.2242906550740043,['H2AFY'],0.9532955575088616,0,0,1
94,Non-homologous end joining WP438,0.3200334802921868,2.8299892125134845,3.2242906550740043,['PRKDC'],0.9532955575088616,0,0,1
95,Genes related to primary cilium development (based on CRISPR) WP4536,0.3277085936707123,1.3421567617674324,1.4973510184306382,"['ARMC9', 'CEP83', 'FGFR1OP', 'TUBD1', 'WDR35']",0.9532955575088616,0,0,5
96,IL-5 signaling pathway WP127,0.3426343046535774,1.6985732814526588,1.8193275189990665,"['SHC1', 'MAPT']",0.9532955575088616,0,0,2
97,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.3426343046535774,1.6985732814526588,1.8193275189990665,"['SHC1', 'AP2A1']",0.9532955575088616,0,0,2
98,p38 MAPK Signaling Pathway WP400,0.3426343046535774,1.6985732814526588,1.8193275189990665,"['SHC1', 'HMGN1']",0.9532955575088616,0,0,2
99,Tryptophan catabolism leading to NAD+ production WP4210,0.34577160899473963,2.5467961165048543,2.704638419321086,['NADSYN1'],0.9532955575088616,0,0,1
100,Disorders of Folate Metabolism and Transport WP4259,0.34577160899473963,2.5467961165048543,2.704638419321086,['MTR'],0.9532955575088616,0,0,1
101,Dopaminergic Neurogenesis WP2855,0.34577160899473963,2.5467961165048543,2.704638419321086,['ALDH1A1'],0.9532955575088616,0,0,1
102,Glutathione metabolism WP100,0.34577160899473963,2.5467961165048543,2.704638419321086,['GSR'],0.9532955575088616,0,0,1
103,GPR40 Pathway WP3958,0.34577160899473963,2.5467961165048543,2.704638419321086,['PLCD1'],0.9532955575088616,0,0,1
104,Homologous recombination WP186,0.34577160899473963,2.5467961165048543,2.704638419321086,['POLD3'],0.9532955575088616,0,0,1
105,Leptin Insulin Overlap WP3935,0.34577160899473963,2.5467961165048543,2.704638419321086,['LEPR'],0.9532955575088616,0,0,1
106,Mammalian disorder of sexual development WP4842,0.34577160899473963,2.5467961165048543,2.704638419321086,['PTGDS'],0.9532955575088616,0,0,1
107,Matrix Metalloproteinases WP129,0.34577160899473963,2.5467961165048543,2.704638419321086,['MMP16'],0.9532955575088616,0,0,1
108,Integrin-mediated Cell Adhesion WP185,0.3499933464383196,1.3594791666666666,1.4272371511458828,"['SHC1', 'CAPN5', 'ITGA7', 'TLN1']",0.9560003444380025,0,0,4
109,22q11.2 copy number variation syndrome WP4657,0.3673196730804776,1.3239650974025974,1.3259811867691902,"['GLUD1', 'XPO1', 'SNAP29', 'DGCR2']",0.9759688119640944,0,0,4
110,IL-2 signaling pathway WP49,0.37027285530954424,1.592169260700389,1.5818441996211974,"['SHC1', 'MAPT']",0.9759688119640944,0,0,2
111,Serotonin and anxiety WP3947,0.3705373116609443,2.3150926743159754,2.298426630244167,['PLCD4'],0.9759688119640944,0,0,1
112,Fatty acid transporters WP5061,0.3705373116609443,2.3150926743159754,2.298426630244167,['FABP5'],0.9759688119640944,0,0,1
113,Omega-3/Omega-6 FA synthesis WP4723,0.3943672592705693,2.1220064724919094,1.9744690361093469,['PLA2G5'],0.9912601617329347,0,0,1
114,Omega-9 FA synthesis WP4724,0.3943672592705693,2.1220064724919094,1.9744690361093469,['ELOVL6'],0.9912601617329347,0,0,1
115,PPAR-alpha pathway WP2878,0.3943672592705693,2.1220064724919094,1.9744690361093469,['CPT2'],0.9912601617329347,0,0,1
116,Riboflavin and CoQ disorders WP5037,0.3943672592705693,2.1220064724919094,1.9744690361093469,['APTX'],0.9912601617329347,0,0,1
117,Folate Metabolism WP176,0.4108171233591205,1.4553640911617565,1.2947022559994328,"['AHCY', 'MTR']",0.9912601617329347,0,0,2
118,Airway smooth muscle cell contraction WP4962,0.41729674260449984,1.9586258401792382,1.7117561291540568,['MYLK'],0.9912601617329347,0,0,1
119,Type II diabetes mellitus WP1584,0.41729674260449984,1.9586258401792382,1.7117561291540568,['CACNA1A'],0.9912601617329347,0,0,1
120,Phytochemical activity on NRF2 transcriptional activation WP3,0.41729674260449984,1.9586258401792382,1.7117561291540568,['EPHB2'],0.9912601617329347,0,0,1
121,SARS coronavirus and innate immunity WP4912,0.41729674260449984,1.9586258401792382,1.7117561291540568,['TRAF3'],0.9912601617329347,0,0,1
122,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.43935972386893135,1.8185852981969486,1.4956714456927713,['ACO1'],0.9912601617329347,0,0,1
123,MAPK pathway in congenital thyroid cancer WP4928,0.43935972386893135,1.8185852981969486,1.4956714456927713,['SHC1'],0.9912601617329347,0,0,1
124,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.43935972386893135,1.8185852981969486,1.4956714456927713,['MYLK'],0.9912601617329347,0,0,1
125,Calcium Regulation in the Cardiac Cell WP536,0.4407166615042368,1.1578011030065825,0.9486479240215022,"['RGS5', 'PKIB', 'CACNA1A', 'ATP2B2', 'CALR']",0.9912601617329347,0,0,5
126,Fragile X Syndrome  WP4549,0.4481591264810127,1.1472823116658732,0.9208167186304641,"['CYFIP2', 'SHC1', 'EIF4EBP2', 'AP2A1', 'GPHN']",0.9912601617329347,0,0,5
127,Circadian rhythm related genes WP3594,0.4570995354402517,1.1154143409188493,0.8732067011018706,"['SETX', 'KDM5A', 'AHCY', 'PRKDC', 'CRY2', 'PTGDS']",0.9912601617329347,0,0,6
128,DNA IR-damage and cellular response via ATR WP4016,0.4580067934241504,1.2125684581824934,0.9468598624135086,"['MSH2', 'PRKDC', 'TDP1']",0.9912601617329347,0,0,3
129,Triacylglyceride synthesis WP325,0.46058888682062005,1.6972168284789644,1.3157663610463828,['AGPAT3'],0.9912601617329347,0,0,1
130,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.46058888682062005,1.6972168284789644,1.3157663610463828,['SETX'],0.9912601617329347,0,0,1
131,miRNA targets in ECM and membrane receptors WP2911,0.46058888682062005,1.6972168284789644,1.3157663610463828,['COL5A2'],0.9912601617329347,0,0,1
132,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.46058888682062005,1.6972168284789644,1.3157663610463828,['EIF3E'],0.9912601617329347,0,0,1
133,Pregnane X receptor pathway WP2876,0.46058888682062005,1.6972168284789644,1.3157663610463828,['DNAJC7'],0.9912601617329347,0,0,1
134,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.46277874796259316,1.3056968971365859,1.0060475614609767,"['CYP27A1', 'TM7SF2']",0.9912601617329347,0,0,2
135,Histone Modifications WP2369,0.46277874796259316,1.3056968971365859,1.0060475614609767,"['SETBP1', 'SMYD5']",0.9912601617329347,0,0,2
136,Apoptosis Modulation and Signaling WP1772,0.46787374420654154,1.193530701754386,0.9065543567039045,"['DFFA', 'AIFM2', 'TRAF3']",0.9912601617329347,0,0,3
137,Eukaryotic Transcription Initiation WP405,0.4753466486836287,1.2729571984435797,0.9467122129774873,"['POLR1A', 'GTF2H3']",0.9912601617329347,0,0,2
138,Alzheimer's disease WP2059,0.47765994774521975,1.1750787224471435,0.8682142066785987,"['BACE1', 'EIF2AK3', 'MAPT']",0.9912601617329347,0,0,3
139,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.48101568482730406,1.5910194174757282,1.1643961531700342,['SHC1'],0.9912601617329347,0,0,1
140,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.48101568482730406,1.5910194174757282,1.1643961531700342,['CPT2'],0.9912601617329347,0,0,1
141,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.48773450545359665,1.2418145582234033,0.8916030674417945,"['PPP1R13B', 'EIF2AK3']",0.9912601617329347,0,0,2
142,Exercise-induced Circadian Regulation WP410,0.48773450545359665,1.2418145582234033,0.8916030674417945,"['CRY2', 'ERC2']",0.9912601617329347,0,0,2
143,One-carbon metabolism and related pathways WP3940,0.48773450545359665,1.2418145582234033,0.8916030674417945,"['GSR', 'MTR']",0.9912601617329347,0,0,2
144,Nuclear Receptors Meta-Pathway WP2882,0.49265831630548623,1.0552813022724492,0.74707522842227,"['SULT1A1', 'CBR1', 'CPT2', 'DNAJC7', 'FTH1', 'TXNRD1', 'GSR', 'PRDX6']",0.9912601617329347,0,0,8
145,Synaptic Vesicle Pathway WP2267,0.4999379403555304,1.212154900870854,0.8403522130826909,"['CACNA1A', 'AP2A1']",0.9912601617329347,0,0,2
146,Urea cycle and associated pathways WP4595,0.500670386773584,1.4973158195316962,1.0358540219144814,['GLUD1'],0.9912601617329347,0,0,1
147,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.500670386773584,1.4973158195316962,1.0358540219144814,['RAB27A'],0.9912601617329347,0,0,1
148,NAD+ biosynthetic pathways WP3645,0.500670386773584,1.4973158195316962,1.0358540219144814,['NADSYN1'],0.9912601617329347,0,0,1
149,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.500670386773584,1.4973158195316962,1.0358540219144814,['NQO2'],0.9912601617329347,0,0,1
150,Joubert Syndrome WP4656,0.5064976815976816,1.1229790161678705,0.763890229165635,"['NEK8', 'ARMC9', 'CEP41']",0.9959801088782945,0,0,3
151,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5195821219589181,1.4140237324703344,0.9258043269294005,['TRAF3'],0.9959801088782945,0,0,1
152,Hippo-Yap signaling pathway WP4537,0.5195821219589181,1.4140237324703344,0.9258043269294005,['TNIK'],0.9959801088782945,0,0,1
153,Peptide GPCRs WP24,0.5195821219589181,1.4140237324703344,0.9258043269294005,['OXTR'],0.9959801088782945,0,0,1
154,G1 to S cell cycle control WP45,0.5237769296856803,1.156880084895649,0.7481420787257532,"['ORC3', 'MCM5']",0.9959801088782945,0,0,2
155,Copper homeostasis WP3286,0.5354065134757542,1.1310851707738867,0.7066216876826884,"['BACE1', 'MAPT']",0.9959801088782945,0,0,2
156,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5354065134757542,1.1310851707738867,0.7066216876826884,"['PRKDC', 'HSF1']",0.9959801088782945,0,0,2
157,VEGFA-VEGFR2 Signaling Pathway WP3888,0.5426205476669329,0.9975001952972424,0.6098167674385774,"['SHC1', 'EIF2AK3', 'AP2A1', 'PLA2G5', 'HMGB1', 'PRDX6', 'MOV10', 'GLUD1', 'TFCP2', 'DHX36', 'TPP1', 'CALR', 'EPHB2', 'FARSB']",0.9959801088782945,0,0,14
158,Sphingolipid Metabolism (general overview) WP4725,0.5552877657645986,1.2724271844660193,0.7485292163740679,['DEGS2'],0.9959801088782945,0,0,1
159,Unfolded protein response WP4925,0.5552877657645986,1.2724271844660193,0.7485292163740679,['EIF2AK3'],0.9959801088782945,0,0,1
160,EPO Receptor Signaling WP581,0.5552877657645986,1.2724271844660193,0.7485292163740679,['SHC1'],0.9959801088782945,0,0,1
161,SARS-CoV-2 mitochondrial interactions WP5038,0.5552877657645986,1.2724271844660193,0.7485292163740679,['TRAF3'],0.9959801088782945,0,0,1
162,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.5580745785402159,1.0827883102905869,0.6315500033235593,"['MAOA', 'HMGA2']",0.9959801088782945,0,0,2
163,Kit receptor signaling pathway WP304,0.5691098704518053,1.0601491569390402,0.5975867527768456,"['SHC1', 'MAPT']",0.9959801088782945,0,0,2
164,Sphingolipid Metabolism (integrated pathway) WP4726,0.5721346117325152,1.2117429496070273,0.6766142158218915,['DEGS2'],0.9959801088782945,0,0,1
165,TLR4 Signaling and Tolerance WP3851,0.5721346117325152,1.2117429496070273,0.6766142158218915,['TRAF3'],0.9959801088782945,0,0,1
166,Toll-like Receptor Signaling related to MyD88 WP3858,0.5721346117325152,1.2117429496070273,0.6766142158218915,['TRAF3'],0.9959801088782945,0,0,1
167,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5721346117325152,1.2117429496070273,0.6766142158218915,['MTA2'],0.9959801088782945,0,0,1
168,Fluoropyrimidine Activity WP1601,0.5721346117325152,1.2117429496070273,0.6766142158218915,['UPP2'],0.9959801088782945,0,0,1
169,NRF2-ARE regulation WP4357,0.5721346117325152,1.2117429496070273,0.6766142158218915,['EPHB2'],0.9959801088782945,0,0,1
170,p53 transcriptional gene network WP4963,0.5799445409457162,1.0384340506630667,0.5657625461345249,"['MSH2', 'ISG15']",0.9959801088782945,0,0,2
171,Endothelin Pathways WP2197,0.588344443408379,1.15657546337158,0.6134970282928282,['MYLK'],0.9959801088782945,0,0,1
172,miRNAs involvement in the immune response in sepsis WP4329,0.588344443408379,1.15657546337158,0.6134970282928282,['TRAF3'],0.9959801088782945,0,0,1
173,Pre-implantation embryo WP3527,0.588344443408379,1.15657546337158,0.6134970282928282,['H2AFY2'],0.9959801088782945,0,0,1
174,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5905779514785108,1.0175875486381323,0.5359161893372618,"['ACTN2', 'ITGA7']",0.9959801088782945,0,0,2
175,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.601009797978909,0.9975585564965286,0.5079009953731425,"['SCARB2', 'TLN1']",0.9959801088782945,0,0,2
176,Tryptophan metabolism WP465,0.6039413026797628,1.1062051498522583,0.5578352156523226,['ALDH1A1'],0.9959801088782945,0,0,1
177,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.6112400869602703,0.978299910206525,0.48158325137955693,"['SHC1', 'MYLK']",0.9959801088782945,0,0,2
178,Pathways affected in adenoid cystic carcinoma WP3651,0.631097432973314,0.941922467214296,0.43356221894796815,"['PRKDC', 'DTX4']",0.9959801088782945,0,0,2
179,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6333877766887794,1.0175533980582525,0.46468859617169905,['CYP11A1'],0.9959801088782945,0,0,1
180,Nanoparticle-mediated activation of receptor signaling WP2643,0.6333877766887794,1.0175533980582525,0.46468859617169905,['TLN1'],0.9959801088782945,0,0,1
181,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.6333877766887794,1.0175533980582525,0.46468859617169905,['CYP11A1'],0.9959801088782945,0,0,1
182,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.6367680297817169,0.9189741421827662,0.4147788414125646,"['UQCRC2', 'UQCR10', 'ATP5ME']",0.9959801088782945,0,0,3
183,AMP-activated protein kinase (AMPK) signaling WP1403,0.6407258540787878,0.9247258577997878,0.41164504303059923,"['LEPR', 'SLC2A4RG']",0.9959801088782945,0,0,2
184,IL17 signaling pathway WP2112,0.6472810816059602,0.9783420463032113,0.4255539798594376,['TRAF3'],0.9959801088782945,0,0,1
185,Intraflagellar transport proteins binding to dynein WP4532,0.6472810816059602,0.9783420463032113,0.4255539798594376,['WDR35'],0.9959801088782945,0,0,1
186,Myometrial relaxation and contraction pathways WP289,0.650776287590596,0.8996819690265486,0.38649378336216356,"['RGS5', 'PKIB', 'OXTR', 'PLCD1']",0.9959801088782945,0,0,4
187,Apoptosis WP254,0.6593873275179384,0.8921428083828248,0.3715276684417426,"['DFFA', 'TRAF3']",0.9959801088782945,0,0,2
188,BDNF-TrkB Signaling WP3676,0.6606488587369035,0.9420352391226178,0.39050451253973945,['SHC1'],0.9959801088782945,0,0,1
189,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.6606488587369035,0.9420352391226178,0.39050451253973945,['TRAF3'],0.9959801088782945,0,0,1
190,MECP2 and Associated Rett Syndrome WP3584,0.6684230473705792,0.8766939487454716,0.35316213142114816,"['TET3', 'TAF1']",0.9959801088782945,0,0,2
191,Alpha 6 Beta 4 signaling pathway WP244,0.6735109494802483,0.9083217753120666,0.3590151133429298,['SHC1'],0.9959801088782945,0,0,1
192,Zinc homeostasis WP3529,0.6735109494802483,0.9083217753120666,0.3590151133429298,['SLC30A9'],0.9959801088782945,0,0,1
193,Neovascularisation processes WP4331,0.6735109494802483,0.9083217753120666,0.3590151133429298,['EPHB2'],0.9959801088782945,0,0,1
194,PDGFR-beta pathway WP3972,0.6735109494802483,0.9083217753120666,0.3590151133429298,['SHC1'],0.9959801088782945,0,0,1
195,Cell cycle WP179,0.6816517558714805,0.8566265851895657,0.32829046590012845,"['PRKDC', 'ORC3', 'MCM5']",0.9959801088782945,0,0,3
196,ATM Signaling Pathway WP2516,0.685886447563739,0.8769333779712085,0.33064176113313193,['AP3B2'],0.9959801088782945,0,0,1
197,Fatty acid beta-oxidation WP143,0.685886447563739,0.8769333779712085,0.33064176113313193,['CPT2'],0.9959801088782945,0,0,1
198,"GPCRs, Other WP117",0.685886447563739,0.8769333779712085,0.33064176113313193,['GPR143'],0.9959801088782945,0,0,1
199,Neural Crest Cell Migration during Development WP4564,0.685886447563739,0.8769333779712085,0.33064176113313193,['EPHB2'],0.9959801088782945,0,0,1
200,Adipogenesis WP236,0.6887175608397446,0.847043534762833,0.315882878593966,"['GDF10', 'ASIP', 'PLIN2']",0.9959801088782945,0,0,3
201,The influence of laminopathies on Wnt signaling WP4844,0.6977937271341909,0.8476375404530744,0.3050068908666261,['HMGA2'],0.9959801088782945,0,0,1
202,Oxidative Damage WP3941,0.6977937271341909,0.8476375404530744,0.3050068908666261,['TRAF3'],0.9959801088782945,0,0,1
203,mRNA Processing WP411,0.7011253828855993,0.8396823347107438,0.29814478489162805,"['SF3B3', 'SNRPD1', 'SNRPF', 'CLK3']",0.9959801088782945,0,0,4
204,"GPCRs, Class A Rhodopsin-like WP455",0.7026382884280507,0.8198820133048826,0.2893470580956802,"['OXTR', 'GPR35']",0.9959801088782945,0,0,2
205,Neural Crest Differentiation WP2064,0.7026382884280507,0.8198820133048826,0.2893470580956802,"['PRTG', 'DCT']",0.9959801088782945,0,0,2
206,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7092504697206484,0.8202317569683683,0.2817877845779537,['ACTN2'],0.9959801088782945,0,0,1
207,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.7186173114798616,0.7941391050583657,0.2624044573100073,"['H2AFY2', 'KREMEN1']",0.9959801088782945,0,0,2
208,Allograft Rejection WP2328,0.7202736905815216,0.7945388349514563,0.2607072713215682,['HLA-E'],0.9959801088782945,0,0,1
209,Aryl Hydrocarbon Receptor Netpath WP2586,0.7202736905815216,0.7945388349514563,0.2607072713215682,['PLAGL1'],0.9959801088782945,0,0,1
210,Neural Crest Cell Migration in Cancer WP4565,0.7202736905815216,0.7945388349514563,0.2607072713215682,['EPHB2'],0.9959801088782945,0,0,1
211,Parkinson's disease pathway WP2371,0.7202736905815216,0.7945388349514563,0.2607072713215682,['UBA7'],0.9959801088782945,0,0,1
212,Leptin signaling pathway WP2034,0.7263324891208852,0.7818617180484885,0.2499982475960052,"['SHC1', 'LEPR']",0.9959801088782945,0,0,2
213,Nonalcoholic fatty liver disease WP4396,0.7298286532789433,0.8060515873015873,0.2538623152931839,"['LEPR', 'EIF2AK3', 'UQCRC2', 'UQCR10']",0.9959801088782945,0,0,4
214,Target Of Rapamycin (TOR) Signaling WP1471,0.7308797633489048,0.770403059723448,0.24152622446031147,['RRAGD'],0.9959801088782945,0,0,1
215,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7308797633489048,0.770403059723448,0.24152622446031147,['TRAF3'],0.9959801088782945,0,0,1
216,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7308797633489048,0.770403059723448,0.24152622446031147,['BST2'],0.9959801088782945,0,0,1
217,Ferroptosis WP4313,0.741084444511255,0.7476870359794403,0.22403746682303632,['FTH1'],0.9959801088782945,0,0,1
218,Integrated Cancer Pathway WP1971,0.741084444511255,0.7476870359794403,0.22403746682303632,['MSH2'],0.9959801088782945,0,0,1
219,Nephrotic syndrome WP4758,0.741084444511255,0.7476870359794403,0.22403746682303632,['SCARB2'],0.9959801088782945,0,0,1
220,Hedgehog Signaling Pathway WP4249,0.7509028965516756,0.7262690707350902,0.20806078950365267,['CSNK1G1'],0.9959801088782945,0,0,1
221,IL-6 signaling pathway WP364,0.7509028965516756,0.7262690707350902,0.20806078950365267,['SHC1'],0.9959801088782945,0,0,1
222,PDGF Pathway WP2526,0.7509028965516756,0.7262690707350902,0.20806078950365267,['SHC1'],0.9959801088782945,0,0,1
223,IL-3 signaling pathway WP286,0.7694389259716443,0.6869063237995277,0.18003381811088945,['SHC1'],0.9959801088782945,0,0,1
224,Notch Signaling WP268,0.7694389259716443,0.6869063237995277,0.18003381811088945,['DTX4'],0.9959801088782945,0,0,1
225,Pyrimidine metabolism WP4022,0.775453832228045,0.7054690877648077,0.17940560811180573,"['POLD3', 'POLR1A']",0.9959801088782945,0,0,2
226,Splicing factor NOVA regulated synaptic proteins WP4148,0.7781840551044561,0.6687787429739397,0.167724497679929,['GPHN'],0.9959801088782945,0,0,1
227,Complement system WP2806,0.7781840551044561,0.6687787429739397,0.167724497679929,['CALR'],0.9959801088782945,0,0,1
228,Metabolic reprogramming in colon cancer WP4290,0.7781840551044561,0.6687787429739397,0.167724497679929,['GLUD1'],0.9959801088782945,0,0,1
229,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7865980991066797,0.651580781677869,0.15640404054075602,['SERPINH1'],0.9959801088782945,0,0,1
230,Endochondral Ossification WP474,0.7865980991066797,0.651580781677869,0.15640404054075602,['SERPINH1'],0.9959801088782945,0,0,1
231,Interleukin-11 Signaling Pathway WP2332,0.7865980991066797,0.651580781677869,0.15640404054075602,['BGLAP'],0.9959801088782945,0,0,1
232,Vitamin D Receptor Pathway WP2877,0.7940376397420065,0.677094682230869,0.15615456406958358,"['BGLAP', 'CD9']",0.9959801088782945,0,0,2
233,Wnt signaling pathway and pluripotency WP399,0.7940376397420065,0.677094682230869,0.15615456406958358,"['PPP2R2C', 'PPP2R2B']",0.9959801088782945,0,0,2
234,Androgen receptor signaling pathway WP138,0.8056602825174861,0.6594067411188034,0.1424932541264017,"['ZMIZ1', 'CALR']",0.9959801088782945,0,0,2
235,Hippo-Merlin Signaling Dysregulation WP4541,0.8112502100857819,0.6509029232764642,0.13615506116304602,"['DDB1', 'ITGA7']",0.9959801088782945,0,0,2
236,Wnt Signaling Pathway WP363,0.8241237876116222,0.5773168578993821,0.11167301661126489,['CSNK1G1'],0.9959801088782945,0,0,1
237,Genotoxicity pathway WP4286,0.8241237876116222,0.5773168578993821,0.11167301661126489,['SEL1L'],0.9959801088782945,0,0,1
238,Regulation of toll-like receptor signaling pathway WP1449,0.8271687068517722,0.6266512946149781,0.1189049563937978,"['RNF31', 'TRAF3']",0.9959801088782945,0,0,2
239,Regulation of Actin Cytoskeleton WP51,0.8288748111653249,0.6616323417238749,0.12417922502389014,"['CYFIP2', 'MYL3', 'MYLK']",0.9959801088782945,0,0,3
240,IL-4 signaling pathway WP395,0.8307981484132465,0.5644444444444444,0.10463017239585766,['SHC1'],0.9959801088782945,0,0,1
241,Male infertility WP4673,0.8322005873067562,0.6189617538198728,0.11369199465447805,"['PIWIL2', 'MTR']",0.9959801088782945,0,0,2
242,Hepatitis B infection WP4666,0.8414030033906736,0.6446625037169195,0.11132324682411712,"['DDB1', 'TRAF3', 'HSPG2']",0.9959801088782945,0,0,3
243,DNA damage response (only ATM dependent) WP710,0.8418698291449522,0.6041319251435983,0.10398915209768507,"['SHC1', 'HMGB1']",0.9959801088782945,0,0,2
244,RANKL/RANK signaling pathway WP2018,0.843397976419596,0.5403429043586035,0.09202922418637847,['TRAF3'],0.9959801088782945,0,0,1
245,DNA damage response WP707,0.8550612132175924,0.5182088369328314,0.08114228917861042,['PRKDC'],0.9959801088782945,0,0,1
246,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8550612132175924,0.5182088369328314,0.08114228917861042,['NDUFAF2'],0.9959801088782945,0,0,1
247,Oxidative phosphorylation WP623,0.8550612132175924,0.5182088369328314,0.08114228917861042,['ATP5ME'],0.9959801088782945,0,0,1
248,miRNA regulation of DNA damage response WP1530,0.8658573539145978,0.497810774795355,0.07170222588896338,['PRKDC'],0.9959801088782945,0,0,1
249,Notch Signaling Pathway Netpath WP61,0.8658573539145978,0.497810774795355,0.07170222588896338,['MAPT'],0.9959801088782945,0,0,1
250,Integrated breast cancer pathway WP1984,0.867587255948337,0.608233918128655,0.08639305244934982,"['MSH2', 'ZMIZ1', 'ODC1']",0.9959801088782945,0,0,3
251,Acute viral myocarditis WP4298,0.8709505622137637,0.4882001493651979,0.06745464565853151,['DFFA'],0.9959801088782945,0,0,1
252,AGE/RAGE pathway WP2324,0.8709505622137637,0.4882001493651979,0.06745464565853151,['SHC1'],0.9959801088782945,0,0,1
253,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8758507459644604,0.47895218904561276,0.06348970287897233,['MSH2'],0.9959801088782945,0,0,1
254,3q29 copy number variation syndrome WP4906,0.8805652068220365,0.47004674577490113,0.05978585534168908,['FGFR1OP'],0.9959801088782945,0,0,1
255,Oncostatin M Signaling Pathway WP2374,0.8851009706977311,0.4614651368049426,0.0563234578244387,['SHC1'],0.9959801088782945,0,0,1
256,Ebola Virus Pathway on Host WP4217,0.886555063449571,0.5337292647962318,0.06426743069546056,"['BST2', 'HLA-E']",0.9959801088782945,0,0,2
257,Endoderm differentiation WP2853,0.8933037687457912,0.5226443098399455,0.05896922022700316,"['EPB41L5', 'LRPPRC']",0.9959801088782945,0,0,2
258,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.893663194889707,0.44520524612502127,0.05005278492429631,['KREMEN1'],0.9959801088782945,0,0,1
259,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8977024201666653,0.4374958151991965,0.047213081128806664,['TTF2'],0.9959801088782945,0,0,1
260,Toll-like Receptor Signaling Pathway WP75,0.8977024201666653,0.4374958151991965,0.047213081128806664,['TRAF3'],0.9959801088782945,0,0,1
261,T-cell receptor (TCR) signaling pathway WP69,0.9053272226093347,0.42284789644012943,0.04205595649378711,['SHC1'],0.9959801088782945,0,0,1
262,Mesodermal commitment pathway WP2857,0.9085772718812923,0.4968337529564355,0.04763410519091997,"['EPB41L5', 'HMGA2']",0.9959801088782945,0,0,2
263,Head and Neck Squamous Cell Carcinoma WP4674,0.9089241722903624,0.41588413178417954,0.03971427588250339,['TRAF3'],0.9959801088782945,0,0,1
264,Prolactin Signaling Pathway WP2037,0.912384712882769,0.40914500469777637,0.037515955307993294,['SHC1'],0.9959801088782945,0,0,1
265,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9157140075675363,0.4026198181537987,0.03545115083320198,['MSH2'],0.9959801088782945,0,0,1
266,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9189170249294523,0.3962985436893204,0.03351078654791516,['SEC31A'],0.9959801088782945,0,0,1
267,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9192975458261742,0.47793847735114897,0.040216342383509636,"['SHC1', 'PDCD6']",0.9959801088782945,0,0,2
268,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.930559263784729,0.3728726442033124,0.02683546323715703,['TTF2'],0.9959801088782945,0,0,1
269,Corticotropin-releasing hormone signaling pathway WP2355,0.9331990913728686,0.3674405515688758,0.025403631775945186,['CYP11A1'],0.9959801088782945,0,0,1
270,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9331990913728686,0.3674405515688758,0.025403631775945186,['MYLK'],0.9959801088782945,0,0,1
271,B Cell Receptor Signaling Pathway WP23,0.9357387480408444,0.36216366158113733,0.02405453259506467,['SHC1'],0.9959801088782945,0,0,1
272,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9405325813872643,0.35204962243797194,0.021583806154109434,['SHC1'],0.9959801088782945,0,0,1
273,Pathways in clear cell renal cell carcinoma WP4018,0.9427939210639252,0.3472004255885091,0.0204527284053091,['SDSL'],0.9959801088782945,0,0,1
274,Spinal Cord Injury WP2431,0.9449694267070144,0.34248228811335607,0.019385423820000348,['PLA2G5'],0.9959801088782945,0,0,1
275,Small cell lung cancer WP4658,0.9490758202859456,0.3334184977005621,0.0174266474630832,['TRAF3'],0.9959801088782945,0,0,1
276,Osteoblast differentiation WP4787,0.956393698845687,0.3166504854368932,0.014118061962041196,['PRKDC'],0.9959801088782945,0,0,1
277,ErbB signaling pathway WP673,0.9596489840259635,0.3088799431683637,0.01272205536900436,['SHC1'],0.9959801088782945,0,0,1
278,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9598093418348329,0.4899878640776699,0.020099604261825946,"['PPP2R2C', 'PPP2R2B', 'COL5A2', 'ITGA7']",0.9959801088782945,0,0,4
279,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9599877501171634,0.39512402723735407,0.016134792805872298,"['SHC1', 'MAPT']",0.9959801088782945,0,0,2
280,PI3K-Akt signaling pathway WP4172,0.9638639424027055,0.4805059523809524,0.017685085445744007,"['PPP2R2C', 'PPP2R2B', 'ITGA7', 'SGK2']",0.9959801088782945,0,0,4
281,Wnt signaling WP428,0.9640827466972715,0.2979097658480868,0.010896988468819563,['KREMEN1'],0.9959801088782945,0,0,1
282,7q11.23 copy number variation syndrome WP4932,0.9680301373691207,0.2876875551632833,0.009347560884865333,['EIF2AK3'],0.9959801088782945,0,0,1
283,Thermogenesis WP4321,0.9715444172146258,0.2781393363917636,0.008029407292679475,['CPT2'],0.9959801088782945,0,0,1
284,Gastrin signaling pathway WP4659,0.9726279514365345,0.27509497678345296,0.007634887651162284,['SHC1'],0.9959801088782945,0,0,1
285,Ras signaling WP4223,0.9729671964239045,0.36092273485269594,0.009891055503933871,"['SHC1', 'PLA2G5']",0.9959801088782945,0,0,2
286,EGF/EGFR signaling pathway WP437,0.9738431167275226,0.35833540304109057,0.009497701155121245,"['SHC1', 'AP2A1']",0.9959801088782945,0,0,2
287,Insulin Signaling WP481,0.9738431167275226,0.35833540304109057,0.009497701155121245,"['SHC1', 'SGK2']",0.9959801088782945,0,0,2
288,Chemokine signaling pathway WP3929,0.9821447365104438,0.24550853049297766,0.004423227018212228,['SHC1'],0.9959801088782945,0,0,1
289,TGF-beta Signaling Pathway WP366,0.9852978017678768,0.23405249910104278,0.0034666327065439985,['SHC1'],0.9959801088782945,0,0,1
290,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9858582873956416,0.23188741426917253,0.003302693474441029,['MAOA'],0.9959801088782945,0,0,1
291,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9878948676310748,0.22361027579688977,0.0027233486939401094,['SHC1'],0.9959801088782945,0,0,1
292,Breast cancer pathway WP4262,0.9878948676310748,0.22361027579688977,0.0027233486939401094,['SHC1'],0.9959801088782945,0,0,1
293,Ectoderm Differentiation WP2858,0.9892277013604754,0.2177770338131905,0.0023586864149650845,['HMGB2'],0.9959801088782945,0,0,1
294,MAPK Signaling Pathway WP382,0.9954866393095101,0.2607407108727647,0.0011794805922750724,"['CACNA1A', 'MAPT']",0.9988726482867533,0,0,2
295,IL-18 signaling pathway WP4754,0.9992073165971842,0.13733354554618282,0.00010890519157801056,['PYGB'],0.9992073165971842,0,0,1
